To Top

Resources and Materials

The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) is an integrated database and analytics hub that is designed to be used in building novel tools to accelerate drug development across rare diseases. It has been developed by the Critical Path Institute (C-Path) and the National Organization for Rare Disorders (NORD) through a collaborative grant from the U.S. Food and Drug Administration (FDA). Data for the platform is shared from various sources including clinical data from industry, research data from academics, patient registry data from NORD and other patient registry sources willing to share. Types of accepted data will continue to expand as the platform develops. RDCA-DAP and logo are a registered trademarks of C-Path.